Nalorphine
From Wikipedia, the free encyclopedia
Nalorphine
|
|
Systematic (IUPAC) name | |
(−)−(5R,6S)-9α-allyl-4,5-epoxymorphin-7-en-3,6-diol | |
Identifiers | |
CAS number | |
ATC code | V03 |
PubChem | |
Chemical data | |
Formula | C19H21NO3 |
Mol. mass | 311.375 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Nalorphine (INN, also known as N-allyl-normorphine) trade names Lethidrone and Nalline. Nalorphine acts at two opioid receptors, at the mu receptor it has antagonistic effects and at the kappa receptors it exerts agonistic characteristics. It is used to reverse opioid overdose and in a challenge test to determine opioid dependence.
|